Sign In
Buy RGEN
$121.73
+0.600 (+0.495%)
At Close: Jun 03, 2026
Repligen Corporation to Present at Evercore Healthcare Conference
07:30am, Wednesday, 26'th Nov 2025
WALTHAM, Mass., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participat
Repligen Corporation (RGEN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript
02:48pm, Tuesday, 18'th Nov 2025
Repligen Corporation ( RGEN ) 7th Annual Wolfe Research Healthcare Conference November 18, 2025 12:40 PM EST Company Participants Jason Garland - CFO & Chief Compliance Officer Steven Chehames Confere
Repligen Corporation (RGEN) Presents at Jefferies London Healthcare Conference 2025 Transcript
11:18am, Tuesday, 18'th Nov 2025
Repligen Corporation ( RGEN ) Jefferies London Healthcare Conference 2025 November 18, 2025 8:30 AM EST Company Participants Olivier Loeillot - President, CEO & Director Conference Call Participants M
Repligen: Rare Growth In The Biopharma Supplies Industry
03:28am, Friday, 14'th Nov 2025
Repligen stands out as a leading bioprocess supplier, benefiting from secular growth in biologics and industry patent expirations. RGEN's strong balance sheet, recurring organic growth, and strategic
Repligen Corporation (RGEN) Presents at Stifel 2025 Healthcare Conference Transcript
03:11pm, Tuesday, 11'th Nov 2025
Repligen Corporation ( RGEN ) Stifel 2025 Healthcare Conference November 11, 2025 10:00 AM EST Company Participants Olivier Loeillot - President, CEO & Director Conference Call Participants Daniel Ari
Repligen Corporation (RGEN) Presents at UBS Global Healthcare Conference 2025 Transcript
01:41pm, Monday, 10'th Nov 2025
Repligen Corporation ( RGEN ) UBS Global Healthcare Conference 2025 November 10, 2025 11:00 AM EST Company Participants Jason Garland - CFO & Chief Compliance Officer Jacob Johnson - Vice President of
RGEN'S Q3 Earnings Beat Estimates, Revenues Surge Y/Y, Stock Down
12:21pm, Wednesday, 29'th Oct 2025
Repligen posts strong Q3 results with revenue growth and an earnings beat, yet shares dip as tighter EPS guidance tempers investor optimism.
Repligen Corporation (RGEN) Q3 2025 Earnings Call Transcript
05:01pm, Tuesday, 28'th Oct 2025
Repligen Corporation (NASDAQ:RGEN ) Q3 2025 Earnings Call October 28, 2025 8:30 AM EDT Company Participants Jacob Johnson Olivier Loeillot - President, CEO & Director Jason Garland - CFO & Chief Compl
Repligen (RGEN) Q3 Earnings and Revenues Surpass Estimates
09:46am, Tuesday, 28'th Oct 2025
Repligen (RGEN) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.43 per share a year ago.
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
07:30am, Tuesday, 28'th Oct 2025
WALTHAM, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its t
ALKS vs. RGEN: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 21'st Oct 2025
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Alkermes (ALKS) or Repligen (RGEN). But which of these two stocks offers value investors a be
Earnings Preview: Repligen (RGEN) Q3 Earnings Expected to Decline
11:06am, Tuesday, 21'st Oct 2025
Repligen (RGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
US Bancorp DE Sells 1,463 Shares of Repligen Corporation $RGEN
04:00am, Saturday, 18'th Oct 2025
US Bancorp DE cut its stake in Repligen Corporation (NASDAQ: RGEN) by 13.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The f
Repligen to Report Third Quarter 2025 Financial Results
07:30am, Wednesday, 15'th Oct 2025
Webcast and Conference Call to Be Held Tuesday, October 28, 2025, at 8:30 a.m. ET Webcast and Conference Call to Be Held Tuesday, October 28, 2025, at 8:30 a.m. ET
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2025 Transcript
11:37am, Thursday, 25'th Sep 2025
Repligen Corporation (NASDAQ:RGEN ) Bank of America Global Healthcare Conference 2025 September 25, 2025 6:35 AM EDT Company Participants Olivier Loeillot - President, CEO & Director Jason Garland - C
